[31] demonstrated that the elevation of cellular PpIX using celecoxib is related to a down regulation of Akt/NF-kB/MDR1 pathway, thus enhancing the anti-tumor efficacy of SDT. The gene discussed is AKT1; the disease is neoplasm.